Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-31

Clinical Trial Update: Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of CITI-002 in adults with moderate hemorrhoids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CITI-002

Snippet

Sponsor: Citius Pharmaceuticals, Inc. | Conditions: Hemorrhoids | Phase 2 | Status: COMPLETED